Q4 2024 Earnings Call Transcript March 31, 2025 Cytosorbents Corporation beats earnings expectations. Reported EPS is $-0.03, ...
Phillip Chan; Chief Executive Officer, Director; Cytosorbents Corp. Peter Mariani; Chief Financial Officer; Cyt ...
BSO is revolutionizing pre-hospital trauma care with its groundbreaking Whole Blood Program, reinforcing its commitment to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback